128 related articles for article (PubMed ID: 38132573)
21. Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons.
Marwaha RK; Kulkarni KP; Bansal D; Trehan A
Leuk Lymphoma; 2010 Feb; 51(2):261-8. PubMed ID: 20038226
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy.
Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S
Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Outcomes of Modified St Jude Children's Research Hospital Total Therapy XIIIB and XV Protocols for Thai Children With Acute Lymphoblastic Leukemia.
Surapolchai P; Anurathapan U; Sermcheep A; Pakakasama S; Sirachainan N; Songdej D; Pongpitcha P; Hongeng S
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):497-505. PubMed ID: 31103474
[TBL] [Abstract][Full Text] [Related]
24. Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.
McNeer JL; Schmiegelow K
Curr Hematol Malig Rep; 2022 Feb; 17(1):1-14. PubMed ID: 35025035
[TBL] [Abstract][Full Text] [Related]
25. Glymphatic system dysfunction in pediatric acute lymphoblastic leukemia without clinically diagnosed central nervous system infiltration: a novel DTI-ALPS method.
Lin LP; Su S; Hou W; Huang L; Zhou Q; Zou M; Qian L; Cui W; Yang Z; Tang Y; Chen Y
Eur Radiol; 2023 May; 33(5):3726-3734. PubMed ID: 36882529
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
27. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
[TBL] [Abstract][Full Text] [Related]
28. Proportion and Pattern of Central Nervous System Involvement in Acute Leukemia on Diagnosis.
Yeasmin S; Rashid MH; Debnath MR; Rashid MM
Mymensingh Med J; 2022 Jan; 31(1):55-60. PubMed ID: 34999680
[TBL] [Abstract][Full Text] [Related]
29. Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia.
Zheng C; Tang B; Tong J; Liu H; Geng L; Wang X; Ding K; Sun Z
Ann Hematol; 2013 Dec; 92(12):1665-73. PubMed ID: 23793915
[TBL] [Abstract][Full Text] [Related]
30. Neurologic Complications in Patients With Lymphoreticular Malignancy: A Descriptive Cohort Study.
Baloda R; Sharma S; Anand R; Mandal P; Parakh N; Katti B; Singh V; Chandra J
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e885-e891. PubMed ID: 37526372
[TBL] [Abstract][Full Text] [Related]
31. The role of magnetic resonance imaging in the diagnosis of central nervous system involvement in children with acute lymphoblastic leukemia.
Lauer M; Kernen E; Schwabe D; Lehrnbecher T; Porto L
Pediatr Blood Cancer; 2020 Oct; 67(10):e28294. PubMed ID: 32743972
[TBL] [Abstract][Full Text] [Related]
32. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
33. Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.
Gökbuget N; Hartog CM; Bassan R; Derigs HG; Dombret H; Greil R; Hernández-Rivas JM; Huguet F; Intermesoli T; Jourdan E; Junghanss C; Leimer L; Moreno MJ; Reichle A; Ribera J; Schmid M; Serve H; Stelljes M; Stuhlmann R; Hoelzer D;
Haematologica; 2011 Feb; 96(2):238-44. PubMed ID: 20952517
[TBL] [Abstract][Full Text] [Related]
34. Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.
Popov A; Tsaur G; Permikin Z; Fominikh V; Verzhbitskaya T; Riger T; Demina A; Shorikov E; Kustanovich A; Movchan L; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Solodovnikov A; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
Pediatr Blood Cancer; 2022 Sep; 69(9):e29860. PubMed ID: 35713168
[TBL] [Abstract][Full Text] [Related]
35. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
36. CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.
Sirvent N; Suciu S; De Moerloose B; Ferster A; Mazingue F; Plat G; Yakouben K; Uyttebroeck A; Paillard C; Costa V; Simon P; Pluchart C; Poirée M; Minckes O; Millot F; Freycon C; Maes P; Hoyoux C; Cavé H; Rohrlich P; Bertrand Y; Benoit Y;
Arch Pediatr; 2021 Jul; 28(5):411-416. PubMed ID: 34034929
[TBL] [Abstract][Full Text] [Related]
37. Imaging Findings in Children Presenting with CNS Nelarabine Toxicity.
Serrallach BL; Schafer ES; Kralik SK; Tran BH; Huisman TAGM; Wright JN; Morgan LA; Desai NK
AJNR Am J Neuroradiol; 2022 Dec; 43(12):1802-1809. PubMed ID: 36328408
[TBL] [Abstract][Full Text] [Related]
38. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
39. Isolated CNS Relapse in 2 High-Risk B-cell Acute Lymphoblastic Leukemia Patients Following SARS-CoV-2 Infection.
Walker SC; Reppucci JR; Ann Thompson M; Borinstein SC; Friedman DL; Zarnegar-Lumley S
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e723-e727. PubMed ID: 34935738
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of leukoencephalopathy and its potential cognitive sequelae in cancer patients.
Schroyen G; Meylaers M; Deprez S; Blommaert J; Smeets A; Jacobs S; Sunaert S; Sleurs C; Uyttebroeck A
J Chemother; 2020 Nov; 32(7):327-343. PubMed ID: 32799637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
